RPHC.F Stock Overview
Manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rohto Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥20.49 |
| 52 Week High | JP¥26.72 |
| 52 Week Low | JP¥20.49 |
| Beta | -0.094 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 55.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| RPHC.F | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | 0.7% |
| 1Y | n/a | -29.4% | 23.3% |
Return vs Industry: Insufficient data to determine how RPHC.F performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how RPHC.F performed against the US Market.
Price Volatility
| RPHC.F volatility | |
|---|---|
| RPHC.F Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 9.0% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: RPHC.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RPHC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1899 | 7,176 | Yamada Kunio | www.rohto.co.jp |
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams.
Rohto Pharmaceutical Co.,Ltd. Fundamentals Summary
| RPHC.F fundamental statistics | |
|---|---|
| Market cap | US$3.96b |
| Earnings (TTM) | US$197.21m |
| Revenue (TTM) | US$1.73b |
20.1x
P/E Ratio2.3x
P/S RatioIs RPHC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RPHC.F income statement (TTM) | |
|---|---|
| Revenue | JP¥270.84b |
| Cost of Revenue | JP¥113.55b |
| Gross Profit | JP¥157.29b |
| Other Expenses | JP¥126.35b |
| Earnings | JP¥30.94b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 135.60 |
| Gross Margin | 58.07% |
| Net Profit Margin | 11.42% |
| Debt/Equity Ratio | 4.2% |
How did RPHC.F perform over the long term?
See historical performance and comparison